KR960702000A - 귀밑샘염 바이러스로부터의 재조합 항원 및 백신에서의 이것의 사용방법(recombinant antigens from mumps virus and their use in vaccines) - Google Patents

귀밑샘염 바이러스로부터의 재조합 항원 및 백신에서의 이것의 사용방법(recombinant antigens from mumps virus and their use in vaccines)

Info

Publication number
KR960702000A
KR960702000A KR1019950704819A KR19950704819A KR960702000A KR 960702000 A KR960702000 A KR 960702000A KR 1019950704819 A KR1019950704819 A KR 1019950704819A KR 19950704819 A KR19950704819 A KR 19950704819A KR 960702000 A KR960702000 A KR 960702000A
Authority
KR
South Korea
Prior art keywords
vector
protein
denoted
fusion
derived
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1019950704819A
Other languages
English (en)
Korean (ko)
Inventor
볼렌 알렉스
호우아르트 소피에
카를 야코프 노르비 에를링
마르크 바르사니 토마스
Original Assignee
쟝 슈테펜
스미쓰클라인 비참 바이올로지칼스 에스.에이.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 쟝 슈테펜, 스미쓰클라인 비참 바이올로지칼스 에스.에이. filed Critical 쟝 슈테펜
Publication of KR960702000A publication Critical patent/KR960702000A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/033—Fusion polypeptide containing a localisation/targetting motif containing a motif for targeting to the internal surface of the plasma membrane, e.g. containing a myristoylation motif
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18711—Rubulavirus, e.g. mumps virus, parainfluenza 2,4
    • C12N2760/18722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
KR1019950704819A 1993-04-30 1994-04-26 귀밑샘염 바이러스로부터의 재조합 항원 및 백신에서의 이것의 사용방법(recombinant antigens from mumps virus and their use in vaccines) Withdrawn KR960702000A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9308963.9 1993-04-30
GB939308963A GB9308963D0 (en) 1993-04-30 1993-04-30 Novel compounds
PCT/EP1994/001297 WO1994025600A1 (fr) 1993-04-30 1994-04-26 Antigenes recombines du virus ourlien et leur utilisation dans les vaccins

Publications (1)

Publication Number Publication Date
KR960702000A true KR960702000A (ko) 1996-03-28

Family

ID=10734747

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019950704819A Withdrawn KR960702000A (ko) 1993-04-30 1994-04-26 귀밑샘염 바이러스로부터의 재조합 항원 및 백신에서의 이것의 사용방법(recombinant antigens from mumps virus and their use in vaccines)

Country Status (8)

Country Link
EP (1) EP0695358A1 (fr)
JP (1) JPH08512199A (fr)
KR (1) KR960702000A (fr)
CN (1) CN1126492A (fr)
AU (1) AU6964894A (fr)
CA (1) CA2161645A1 (fr)
GB (1) GB9308963D0 (fr)
WO (1) WO1994025600A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6100064A (en) * 1984-04-06 2000-08-08 Chiron Corporation Secreted viral proteins useful for vaccines and diagnostics
CA2283536C (fr) * 1997-03-11 2009-09-01 Cambridge Genetics Limited Compositions et methodes d'elimination de cellules indesirables
AU7915398A (en) * 1997-05-23 1998-12-11 Schwiez. Serum-& Impfinstitut Bern An influenza enveloped dna vaccine
WO2000018929A2 (fr) * 1998-09-25 2000-04-06 Smithkline Beecham Biologicals S.A. Nouveaux composés
CN1843507B (zh) * 2006-02-14 2010-04-21 中国医学科学院医学生物学研究所 一种人用腮腺炎病毒组份疫苗及其制备方法和应用
CN106290862B (zh) * 2016-08-05 2017-10-31 北京市华信行生物科技有限公司 腮腺炎病毒hn抗原及其在检测抗腮腺炎病毒抗体中的用途
WO2021119497A1 (fr) * 2019-12-11 2021-06-17 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Immunogènes des virus des oreillons et de la rougeole et utilisation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989011534A1 (fr) * 1988-05-24 1989-11-30 Board Of Regents, The University Of Texas System Hemagglutinine-neuraminidase du virus des oreillons

Also Published As

Publication number Publication date
GB9308963D0 (en) 1993-06-16
JPH08512199A (ja) 1996-12-24
EP0695358A1 (fr) 1996-02-07
WO1994025600A1 (fr) 1994-11-10
CN1126492A (zh) 1996-07-10
CA2161645A1 (fr) 1994-11-10
AU6964894A (en) 1994-11-21

Similar Documents

Publication Publication Date Title
DE69829668D1 (de) Herstellung und verwendung von rekombinanten influenza a virus m2 konstruktionen und impstoffe
PL363071A1 (pl) Sposoby i kompozycje dla zmniejszenia replikacji HIV-1
NZ514528A (en) Vectors comprising the sequnece for a respiratory syncytial virus (RSV) F protein with a heterologous signal sequence (HSV I gD) for vaccines
KR960022559A (ko) 슈도모나스 에루지노사 막 단백질로부터 유도된 면역원성 하이브리드 단백질 OprF-Oprl
AU585512B2 (en) Antigenic proteins and vaccines containing them and protective antibodies directed to them for prevention of coccidiosis caused by eimeria tenella and eimeria necatrix
ATE298798T1 (de) Fusionsproteine zwischen antigene aminosäuresequenzen und beta - 2- mikroglobulin
AU4826493A (en) Anti-feline immunodeficiency virus (fiv) vaccines
DE69728289D1 (de) Immunoreaktive peptid ctl epitope von menschlichem cytomegalovirus
KR960702000A (ko) 귀밑샘염 바이러스로부터의 재조합 항원 및 백신에서의 이것의 사용방법(recombinant antigens from mumps virus and their use in vaccines)
EP0540645A4 (en) Methods of use of bovine respiratory syncytial virus recombinant dna, proteins vaccines, antibodies, and transformed cells
EP0294469A4 (fr) Vaccins et analyses diagnostiques pour l'haemophilus influenzae.
ATE123525T1 (de) Fusionsproteine der untereinheit b von choleratoxin und eines heterologen antigens und dafür kodierende rekombinante nukleinsäure.
WO1995019371A3 (fr) Expression de proteines de couches superficielles
KR930702522A (ko) 인체의 투명층 단백질 제트피 3 (zp3)
AU3379693A (en) Vaccines and diagnostic assays for haemophilus influenzae
EP1512693A3 (fr) Nouveau polypeptide, ADN codant pour le dit polypeptide, vecteur de recombinaison contenant ledite ADN, virus de recombinaison préparé en utilisant ledit vecteur et son utilistation
Gauss‐Müller et al. Recombinant proteins VP1 and VP3 of hepatitis A virus prime for neutralizing response
WO1993014206A3 (fr) Peptides synthetiques destines a un vaccin contre la rubeole
DE69836647D1 (de) Methode zur herstellung von (poly)peptiden unter verwendung von verkürzten varianten von sv40 'large' t antigen mit einem intakten n terminus
DE3884672D1 (de) Ein synthetisches Nonapeptid zur Verwendung als Adjuvant.
EP0754755A3 (fr) Protéines, fusionnées recombinantes autologues du virus d'Epstein-Barr, trousse d'essais les contenant ainsi que procédé pour la détection d'anticorps spécifiques du virus d'Epstein-Barr
KR950704494A (ko) 수두-대상포진 바이러스(vzv)에 대한 백신(vaccines against varicellazoster virus(vzv))
ES2074965A1 (es) Virus mutante recombinante de rinotraqueitis infecciosa bovina y vacunas que lo contienen.
ES8801127A1 (es) Un procedimiento para preparar una vacuna auto antigena en forma de virus modificado de la viruela vacuna.
Dietzschold et al. Synthesis of an antigenic determinant of the HSV gD that stimulates the induction of virus-neutralizing antibodies and confers protection against a lethal challenge of HSV.

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 19951030

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid